Handelsavisen
prelaunch
Companies Healthcare EFORLM.BK
EF
EFORLM.BK SET (Bangkok) Advanced Medical Equipment & Technology

E for L Aim PCL

Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
0,00 %
Op margin
-5,5 %
ROE
-4,4 %
Net margin
-9,0 %
Debt / equity
0,89
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

E for L Aim PCL provides healthcare equipment and related services in the advanced medical equipment and technology sector.

Business. E for L Aim PCL (EFORLM.BK) is a healthcare company engaged in the advanced medical equipment and technology industry, primarily operating through the sale of healthcare equipment. The firm is headquartered in Thailand and is listed on the Stock Exchange of Thailand (SET). Specific details regarding its operating segments and geographic revenue mix are not available.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryAdvanced Medical Equipment & Technology
ActivityHealthcare Equipment
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
-4,4 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning EFORLM.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to EFORLM.BK. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    E for L Aim PCL (EFORLM.BK) is a healthcare company engaged in the advanced medical equipment and technology industry, primarily operating through the sale of healthcare equipment. The firm is headquartered in Thailand and is listed on the Stock Exchange of Thailand (SET). Specific details regarding its operating segments and geographic revenue mix are not available.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryAdvanced Medical Equipment & Technology
    ActivityHealthcare Equipment
    AI synthesis
    GENERATED

    E for L Aim PCL has a debt-to-equity ratio of 0.89, indicating a moderate reliance on debt financing, and a current ratio of 1.45, suggesting it has sufficient short-term assets to cover its short-term liabilities. However, the company's free cash flow is negative at -13.73 million THB, and its operating cash flow is only 34.40 million THB, which may limit its ability to fund operations and growth without external financing.

    The company's profitability is weak, with a return on equity of -4.44% and a return on assets of -1.71%, both significantly below the industry median for advanced medical equipment and technology firms. These metrics suggest the company is not generating returns that meet the cost of capital or industry benchmarks.

    E for L Aim PCL's revenue is concentrated in a single economic region, with no disclosed segment or geographic diversification in the latest financials. This lack of diversification increases exposure to regional economic and regulatory risks, particularly in the healthcare equipment sector.

    The company's revenue growth is not disclosed in the latest financials, but its operating income and net income are negative, indicating a contraction in profitability. The capital expenditure of -4.38 million THB suggests some investment in growth, but the negative net income and free cash flow indicate that this investment is not yet generating returns.

    The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's net cash is negative after subtracting total debt, which could necessitate additional financing in the near term. However, the dilution risk is low, and no significant dilution sources are identified in the latest filings or transcripts.

    No recent events, such as filings or transcripts, are disclosed in the available data to provide additional context on the company's strategic direction or operational performance.

    Key takeaways
    • E for L Aim PCL has a moderate debt load and sufficient short-term liquidity but is generating negative free cash flow.
    • The company's profitability metrics are significantly below industry medians, indicating poor returns on equity and assets.
    • Revenue is concentrated in a single region, increasing exposure to local economic and regulatory risks.
    • The company is investing in capital expenditures but is not yet generating positive returns on these investments.
    • Liquidity risk is medium, and dilution risk is low, but the company's net cash position is negative.

    Bull / Bear case

    Generated · model-assisted
    BULL CASE · 4

    Net income surged 126.3% year-over-year to 44.6 million THB, signaling a strong recovery in profitability.

    Free cash flow increased 84.3% to 77.8 million THB, demonstrating improved operational cash generation capabilities.

    Return on equity of -4.4% exceeds the cohort median of -4.7%, showing better capital efficiency than peers.

    Long-term debt decreased to 300.7 million THB, reducing leverage and potential interest expense burdens.

    BEAR CASE · 3

    The company carries high credit risk, suggesting significant potential for loan losses or default events.

    Debt-to-equity ratio of 0.89 ranks in the bottom quartile, reflecting excessive leverage compared to peers.

    Cash conversion of -1.54 ranks in the bottom quartile, indicating poor efficiency in generating cash from earnings.

    In focus — financials by report

    Quarterly
    Annual
    QUARTERLYFiled 2017-11-15
    Q3 2017 · Quarter highlights

    Revenue THB 399.5M; Operating income THB 46.8M.

    RevenueTHB 399.5M
    Operating incomeTHB 46.8M
    Net incomeTHB 36.8M
    Free cash flowTHB 36.9M
    EPS
    Operating cash flowTHB 157.9M
    Financials
    Income statement
    RevenueTHB 399.5M
    Gross profitTHB 138.7M
    Operating incomeTHB 46.8M
    Net incomeTHB 36.8M
    Margins
    Gross margin34.7%
    Operating margin11.7%
    Net margin9.2%
    FCF margin9.2%
    Balance sheet
    Total assetsTHB 1.37B
    Total liabilitiesTHB 848.9M
    Total equityTHB 518.6M
    Cash & equivalentsTHB 95.7M
    Long-term debtTHB 394.9M
    Cash flow
    Operating cash flowTHB 157.9M
    CapEx-THB 27.1M
    Free cash flowTHB 36.9M
    SBC
    P&L flow · revenue → net income
    Revenue THB 399.5MOperating costs THB 352.7MTax THB 10.0MNet income THB 36.8M
    Highlights
    • Revenue THB 399.5M
    • Operating income THB 46.8M
    • Net margin 9.2%

    Valuation FY

    Market price
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $502.3M
    Net cash
    -$399.5M
    Current ratio
    1.4
    Debt / equity
    0.9
    ROA
    -1.7%
    ROE
    -4.4%
    Cash conversion
    -154.0%
    CapEx / revenue
    -1.8%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin-5,5 %Above median
    Net Margin-9,0 %Above median
    ROE-4,4 %Below median
    Capex / Rev-1,8 %Above median
    D/E0,89Bottom quartile
    Cash Conv-1,54Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • E for L Aim PCL Market data — financials · 2026-05-27

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    EFORLM.BKCanonical
    SET (Bangkok) · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2017-11-15 06:50 UTCEARNINGSQuarterly results — Q3 2017 Revenue THB 399.5M · Net THB 36.8M
    2017-08-15 14:30 UTCEARNINGSQuarterly results — Q2 2017 Revenue THB 249.2M · Net THB -20.5M
    2016-03-01 05:46 UTCEARNINGSAnnual results — FY 2016 Revenue THB 1.49B · Net THB 53.0M
    2015-03-02 07:54 UTCEARNINGSAnnual results — FY 2015 Revenue THB 2.17B · Net THB 812.0M
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage